Tali Digital Ltd
AASX:TD10.08
AUD
+0.00
(-1.30%)
ISIN
AU0000074221
Return %
Stock
S&P 500
1Y
-24.00
14.20
3Y
-24.00
81.12
5Y
-96.71
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- David Lionel Brookes
- Full Time Employees
- 5
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 117 Camberwell Road Hawthorn East VIC Australia 3123
- IPO Date
- Sep 23, 2004
- Website
- talidigital.com.au
- Similar Companies
- Business
- TALi Digital Limited operates as a digital health company specializing in the development and commercialization of diagnostic and therapeutic software solutions aimed at improving cognitive function and behavior, particularly in children with attention difficulties. Its core products include TALi DETECT, an evidence-based digital screening tool designed to identify attention-related issues in early childhood; TALi TRAIN, a play-based digital therapeutic program that improves attention skills; and ReadyAttentionGo, an Australian medical device combining app-based digital games and a web portal for healthcare providers to assess and enhance selective, sustained, and executive attention in children aged three to ten years. The company’s platform targets cognitive attention skills and extends its applications to conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. TALi Digital serves primarily the Australian market with growing international engagement. Founded in 2004 and headquartered in Camberwell, Victoria, Australia, TALi Digital underwent a significant brand transformation from its former name, Novita Healthcare Limited, to its current identity in December 2019. Among its latest major operational developments, effective November 2025, the company relocated its registered office and principal place of business to Suite 1.01, 117 Camberwell Road, Hawthorn East, VIC. TALi Digital has also secured strategic partnerships and industry recognitions, including Google for Education Partner status to enhance its digital product reach through co-marketing activities. Furthermore, it has achieved trademark registration for TALi in China, facilitating entry into high-value international markets. The company actively collaborates in clinical research, including a recent collaboration with the Duke Clinical Research Institute in the US to validate its cognitive impairment technology platform. TALi Digital’s product suite leverages patented digital therapeutics technology to deliver scalable, evidence-based cognitive training programs, with a strong emphasis on early childhood intervention. Its technology ecosystem combines mobile apps, web platforms, and therapeutic games underpinned by robust clinical research. The company's offerings are designed to provide healthcare practitioners with actionable insights into cognitive attention domains, enhancing the diagnosis and treatment of developmental neurological conditions. TALi Digital operates within the healthcare and medical technology industries and maintains a small but specialized workforce supporting R&D, commercialization, and market expansion initiatives. Its strategic focus remains on innovation in digital cognitive care with initiatives expanding beyond Australia into Asian and North American markets.